Emergency Contraception in Norway
Emergency contraception pills are used in Norway as an emergency situation after unprotected intercourse or contraceptive failure. Emergency contraception can be purchased with or without a prescription, and is intended to prevent unwanted pregnancy. The main aim of the Norwegian health authorities is to make these emergency contraception pills available to all women who need them. Therefore, emergency contraceptives are widely available without prescription from chemists/pharmacies and mass...
Euromonitor International's Emergency Contraception in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Emergency Contraception in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Emergency Contraception market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2007-2012
Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
Table 3 Emergency Contraception Company Shares by Value 2008-2012
Table 4 Emergency Contraception Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Nycomed Pharma As in Consumer Health (norway)
Strategic Direction
Key Facts
Summary 1 Nycomed Pharma AS: Key Facts
Summary 2 Nycomed Pharma AS: Operational Indicators
Company Background
Production
Summary 3 Nycomed Pharma AS: Production Statistics 2012
Competitive Positioning
Summary 4 Nycomed Pharma AS: Competitive Position 2012
Executive Summary
Moderate Growth in Value Sales in 2012
Consumers Are More Concerned About Their Wellbeing
Further Consumer Segmentation
Adoption of the Internet As A Key Distribution Channel
Modest Increase Is Expected, Driven by the Norwegian Economy
Key Trends and Developments
New Product Development Focuses on Wider Demographic Segments
Concerns About Health and Wellbeing Have A Positive Impact on Consumer Health
the Internet Offers Great Opportunities for Consumer Health Products
the Strong Norwegian Economy Increases Consumers' Confidence in Spending
Government Regulations Impact the Health Sector
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Bioequivalent/generics
Combination Products
Advertising
Packaging
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 5 OTC - Switches 2010-2012
Definitions
Sources
Summary 6 Research Sources
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2007-2012
Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
Table 3 Emergency Contraception Company Shares by Value 2008-2012
Table 4 Emergency Contraception Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Nycomed Pharma As in Consumer Health (norway)
Strategic Direction
Key Facts
Summary 1 Nycomed Pharma AS: Key Facts
Summary 2 Nycomed Pharma AS: Operational Indicators
Company Background
Production
Summary 3 Nycomed Pharma AS: Production Statistics 2012
Competitive Positioning
Summary 4 Nycomed Pharma AS: Competitive Position 2012
Executive Summary
Moderate Growth in Value Sales in 2012
Consumers Are More Concerned About Their Wellbeing
Further Consumer Segmentation
Adoption of the Internet As A Key Distribution Channel
Modest Increase Is Expected, Driven by the Norwegian Economy
Key Trends and Developments
New Product Development Focuses on Wider Demographic Segments
Concerns About Health and Wellbeing Have A Positive Impact on Consumer Health
the Internet Offers Great Opportunities for Consumer Health Products
the Strong Norwegian Economy Increases Consumers' Confidence in Spending
Government Regulations Impact the Health Sector
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Bioequivalent/generics
Combination Products
Advertising
Packaging
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 5 OTC - Switches 2010-2012
Definitions
Sources
Summary 6 Research Sources
